
The Consent & Disclosure Recommendations (CADRe) workgroup was part of the ClinGen resource. Our research focused on development of an ethical framework with an emphasis on consent and diclosure by non-genetic providers. Some of our publications are noted below:

Our rare disease work foucses on equitable access to treatment. This ranges from ensuring that all children have oppritunities for medical treatment regardless of genetic diagnosis or access to high cost therapeutics. Some of our publications on ethical issues in the treatment of rare diseases are noted below
University of Colorado Anschutz
12800 E. 17th Ave
RC1 North, P18-3401A
Mail stop 8313
Aurora, CO 80045